Huntington DiseaseMtINCT05270681
Move to Improve: Telehealth Exercise to Music for HD
A study testing Movement to Music in people with Huntington Disease, run by Ohio State University at 1 site in United States.
Trial summary
The purpose of this study is to determine if a movement to music exercise program delivered via telehealth is feasible and safe for individuals with neurodegenerative disease and their caregivers (Aim 1). Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Huntington Disease
- What is being tested?
- Movement to Music
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Nov 2021to 14 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- confirmed diagnosis of a degenerative neurologic disorder such as HD, PD, mild dementia or mild cognitive impairment
- above the age of 21 years
- has a care partner who can assist with the program.
- able to access the online exercise program
- able to understand study and provide consent.
- stable medication regime for four weeks prior to initiation of trial, and anticipated to be able to maintain a stable regime for the course of trial
- OR regularly assisting in the care for an individual that meet the above criteria (for care partners)
Who cannot join
- any physical or psychiatric condition that would prohibit the participant from completing the intervention or the full battery of assessments
- unable to understand or communicate in spoken English
- currently involved in any intervention trial or within four weeks of completing an intervention trial
- current, regular participation in a structured exercise program three times per week or more
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Move to Improve: Telehealth Exercise and Music Intervention for Individuals With Huntington's Disease
The purpose of this study is to determine if a movement to music exercise program delivered via telehealth is feasible and safe for individuals with neurodegenerative disease and their caregivers (Aim 1). A secondary aim will be to determine if a movement to music exercise program delivered via telehealth improves balance, cognition, mobility, and quality of life (Aim 2).
Read the detailed description
The purpose of this study is to determine if a movement to music exercise program created for our clinic patients, called "Move to Improve," delivered via telehealth is possible and safe for individuals with neurodegenerative disease. Investigators also hope to determine if this telehealth movement to music exercise program improves balance, cognition, mobility, and quality of life. Participants will be asked to participate in a movement to music exercise program that will be accessible by video twice a week for 12 weeks and complete assessments before starting and after completing the program. Participants will be recruited from the OSU Neurology Clinic which serves a large regional area, including rural Appalachian counties. Participants will be ages 21 or older with a confirmed diagnosis of a degenerative neurologic disorder such as Huntington's disease who can access a computer, tablet, or smartphone, can complete the exercises, and have a care partner. Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which are accessible by computer or tablet 24/7 via a hyperlink. This link will be accessible to the community. Here is a link to an example of the class lead by the instructor for this study: https://www.youtube.com/watch?v=NdoPi9YXoWg. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care givers will be also participate in the exercise class and will be present to ensure safety. The care giver and participant will be instructed to stand at a counter or behind a chair for safety during exercise. Participants within driving distance will come to the MEND lab for in-person outcome measures at baseline and after the 12 week intervention. Assessments will also be administered to all participants via telehealth. For those individuals who are not able to come to the lab for assessment due to distance or other reasons, tests will only be administered via telehealth. These individuals will be consented via phone. Telehealth exercise classes will be conducted using a virtual meeting platform such as Zoom, Microsoft Teams, or FaceTime. Caregivers will be present during all assessments to ensure safety.
- Conditions
- Huntington Disease
- Being tested
- Movement to Music
- Keywords
- Huntington, HD, Exercise, Telehealth, Dance
- Medical subject headings
- Huntington Disease, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Movement to MusicOther
Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which will be accessible by computer or tablet 24/7 via a hyperlink. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care partners will be present during each class to ensure safety and will also participate in the Move to Improve exercise program. The care partner and participant will be instructed to stand at a counter or behind a chair for safety during exercise.
| Study group | Role | What they receive |
|---|---|---|
| Individuals with HD | Experimental | Participants with a confirmed diagnosis of Huntington's disease Receives: Other: Movement to Music |
| Care Partners | Experimental | Participants' care partners Receives: Other: Movement to Music |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in 4 stage balance test from baseline: feet together from baseline
How long a participant can stand with feet together up to 10 seconds
Measured: 12 weeks
Change in 4 stage balance test from baseline: feet together from baseline - TELEHEALTH
How long a participant can stand with feet together up to 10 seconds collected via telehealth
Measured: 12 weeks
Change in 4 stage balance test from baseline: feet staggered from baseline
How long a participant can stand with feet staggered up to 10 seconds
Measured: 12 weeks
Change in 4 stage balance test from baseline: feet staggered from baseline - TELEHEALTH
How long a participant can stand with feet staggered up to 10 seconds collected via telehealth
Measured: 12 weeks
Change in 4 stage balance test from baseline: feet in tandem from baseline
How long a participant can stand with feet heel to toe up to 10 seconds
Measured: 12 weeks
Change in 4 stage balance test from baseline: feet in tandem from baseline - TELEHEALTH
How long a participant can stand with feet heel to toe up to 10 seconds collected via telehealth
Measured: 12 weeks
Change in 4 stage balance test from baseline: single leg stance from baseline
How long a participant can stand on one foot to toe up to 60 seconds
Measured: 12 weeks
Change in 4 stage balance test from baseline: single leg stance from baseline - TELEHEALTH
How long a participant can stand on one foot to toe up to 60 seconds collected via telehealth
Measured: 12 weeks
Change in 5 Times Sit to Stand Test from baseline
How long a participant can stand up and sit down from a standard chair with arms crossed across chest in seconds
Measured: 12 weeks
Change in 5 Times Sit to Stand Test from baseline - TELEHEALTH
How long a participant can stand up and sit down from a standard chair with arms crossed across chest in seconds collected via telehealth
Measured: 12 weeks
Change in Adapted Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire from baseline
A patient-reported outcome measure that assesses perceived difficulty in completing physical tasks.
Measured: 12 weeks
Change in Patient Health Questionnaire (PHQ-9) from baseline
A self-administered instrument for depression module, which scores each of the items as "0" (not at all) to "3" (nearly every day), with higher scores indicating worse depression
Measured: 12 weeks
Change in Patient Health Questionnaire (PHQ-9) from baseline - TELEHEALTH
A self-administered instrument for depression module, which scores each of the items as "0" (not at all) to "3" (nearly every day), with higher scores indicating worse depression. Collected via telehealth
Measured: 12 weeks
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline
A patient reported outcome measure containing 12 items that the participant rates his or her difficulties in maintaining personal care, occupational tasks and functioning in relation to family and society with a score range from 12 to 60, where higher scores indicate higher disability or loss of function.
Measured: 12 weeks
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline - TELEHEALTH
A patient reported outcome measure containing 12 items that the participant rates his or her difficulties in maintaining personal care, occupational tasks and functioning in relation to family and society with a score range from 12 to 60, where higher scores indicate higher disability or loss of function. Collected via telehealth
Measured: 12 weeks
Change in verbal fluency from baseline
A measure of cognition that involves asking the participant to name as many animals as they can in 60 seconds and then they are given a letter and asked to name all of the words that begin with that letter in 60 seconds. The more words the better the outcome.
Measured: 12 weeks
Change in verbal fluency from baseline - TELEHEALTH
A measure of cognition that involves asking the participant to name as many animals as they can in 60 seconds and then they are given a letter and asked to name all of the words that begin with that letter in 60 seconds. The more words the better the outcome. Collected via telehealth.
Measured: 12 weeks
Change in Digit Span test from baseline
A measure of cognition that involves asking the participant to recall a series of numbers. The more numbers recalled accurately the better the outcome.
Measured: 12 weeks
Change in Digit Span test from baseline - TELEHEALTH
A measure of cognition that involves asking the participant to recall a series of numbers. The more numbers recalled accurately the better the outcome. Collected via telehealth
Measured: 12 weeks
Secondary outcomes (5)
Change in Unified Huntington's Disease Rating Scale (UHDRS) Motor Scale from baseline
UHDRS Motor Scale is administered by a trained rater who has the individual perform tasks such as tapping fingers and standing up and walking. The rater then scores performance on a scale of 0-4. Higher scores indicates worse outcomes
Measured: 12 weeks
Change in Unified Huntington's Disease Rating Scale (UHDRS) Functional Assessment scale from baseline
A questionnaire that participants fill out rating their difficulty dealing with life situations on a yes or no scale
Measured: 12 weeks
Change in Unified Huntington's Disease Rating Scale (UHDRS) Independence scale from baseline
A questionnaire that participants fill out rating their difficulty performing tasks on a scale of 10-100 with 100 indicating independence
Measured: 12 weeks
Change in Symbol Digit Modality Test (SDMT) from baseline
The SDMT is a part of the standard cognitive battery used with Huntington's disease that involves a simple substitution task, using a reference key, the examinee has 90 seconds to pair specific numbers with given geometric figures.
Measured: 12 weeks
Change in the Stroop interference test from baseline
The Stroop is a part of the standard cognitive battery used with Huntington's disease that involves participants to read three different tables as fast as possible. Two of them represent the "congruous condition" in which participants are required to read names of colors (henceforth referred to as color-words) printed in black ink (W) and name different color patches (C). Conversely, in the third table, named color-word (CW) condition, color-words are printed in an inconsistent color ink (for instance the word "red" is printed in green ink).
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2022
- Study start8 Nov 2021
- Primary completion14 Nov 2024
- Study completion14 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Huntington DiseaseStudies of the same condition, open and under way.
- More trials run by Ohio State UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ohio State University
- Sponsor type
- University, hospital or other
- Collaborators
- Huntington's Disease Society of America
- Responsible party
- Principal investigator, Deb Kegelmeyer, Ohio State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05270681
- Sponsor's protocol ID
- 2021H0219
- Acronym
- MtI
- Status last verified
- Jul 2025
- First submitted
- 25 Feb 2022
- Last updated
- 30 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Move to Improve: Telehealth Exercise and Music Intervention for Individuals With Huntington's Disease
- ClinicalTrials.gov ID
- NCT05270681
- Acronym / sponsor ID
- MtI / 2021H0219
- Conditions
- Huntington Disease
- Keywords
- Huntington, HD, Exercise, Telehealth, Dance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Ohio State UniversityUniversity, hospital or other
- Collaborators
- Huntington's Disease Society of America
- Study start
- 8 Nov 2021 (actual)
- Primary completion
- 14 Nov 2024 (actual)
- Study completion
- 14 Nov 2024 (actual)
- First posted
- 8 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine if a movement to music exercise program delivered via telehealth is feasible and safe for individuals with neurodegenerative disease and their caregivers (Aim 1). A secondary aim will be to determine if a movement to music exercise program delivered via telehealth improves balance, cognition, mobility, and quality of life (Aim 2).
Detailed description
The purpose of this study is to determine if a movement to music exercise program created for our clinic patients, called "Move to Improve," delivered via telehealth is possible and safe for individuals with neurodegenerative disease. Investigators also hope to determine if this telehealth movement to music exercise program improves balance, cognition, mobility, and quality of life. Participants will be asked to participate in a movement to music exercise program that will be accessible by video twice a week for 12 weeks and complete assessments before starting and after completing the program. Participants will be recruited from the OSU Neurology Clinic which serves a large regional area, including rural Appalachian counties. Participants will be ages 21 or older with a confirmed diagnosis of a degenerative neurologic disorder such as Huntington's disease who can access a computer, tablet, or smartphone, can complete the exercises, and have a care partner. Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which are accessible by computer or tablet 24/7 via a hyperlink. This link will be accessible to the community. Here is a link to an example of the class lead by the instructor for this study: https://www.youtube.com/watch?v=NdoPi9YXoWg. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care givers will be also participate in the exercise class and will be present to ensure safety. The care giver and participant will be instructed to stand at a counter or behind a chair for safety during exercise. Participants within driving distance will come to the MEND lab for in-person outcome measures at baseline and after the 12 week intervention. Assessments will also be administered to all participants via telehealth. For those individuals who are not able to come to the lab for assessment due to distance or other reasons, tests will only be administered via telehealth. These individuals will be consented via phone. Telehealth exercise classes will be conducted using a virtual meeting platform such as Zoom, Microsoft Teams, or FaceTime. Caregivers will be present during all assessments to ensure safety.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Individuals with HD | Experimental | Other: Movement to MusicParticipants with a confirmed diagnosis of Huntington's disease |
| Care Partners | Experimental | Other: Movement to MusicParticipants' care partners |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- confirmed diagnosis of a degenerative neurologic disorder such as HD, PD, mild dementia or mild cognitive impairment
- above the age of 21 years
- has a care partner who can assist with the program.
- able to access the online exercise program
- able to understand study and provide consent.
Key exclusion criteria (4 listed)
- any physical or psychiatric condition that would prohibit the participant from completing the intervention or the full battery of assessments
- unable to understand or communicate in spoken English
- currently involved in any intervention trial or within four weeks of completing an intervention trial
- current, regular participation in a structured exercise program three times per week or more
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Movement to MusicParticipants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which will be accessible by computer or tablet 24/7 via a hyperlink. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care partners will be present during each class to ensure safety and will also participate in the Move to Improve exercise program. The care partner and participant will be instructed to stand at a counter or behind a chair for safety during exercise. | Other | Care Partners, Individuals with HD |
Primary outcome
Change in 4 stage balance test from baseline: feet together from baseline
Time frame: 12 weeks
How long a participant can stand with feet together up to 10 seconds
Change in 4 stage balance test from baseline: feet together from baseline - TELEHEALTH
Time frame: 12 weeks
How long a participant can stand with feet together up to 10 seconds collected via telehealth
Change in 4 stage balance test from baseline: feet staggered from baseline
Time frame: 12 weeks
How long a participant can stand with feet staggered up to 10 seconds
Change in 4 stage balance test from baseline: feet staggered from baseline - TELEHEALTH
Time frame: 12 weeks
How long a participant can stand with feet staggered up to 10 seconds collected via telehealth
Change in 4 stage balance test from baseline: feet in tandem from baseline
Time frame: 12 weeks
How long a participant can stand with feet heel to toe up to 10 seconds
Change in 4 stage balance test from baseline: feet in tandem from baseline - TELEHEALTH
Time frame: 12 weeks
How long a participant can stand with feet heel to toe up to 10 seconds collected via telehealth
Change in 4 stage balance test from baseline: single leg stance from baseline
Time frame: 12 weeks
How long a participant can stand on one foot to toe up to 60 seconds
Change in 4 stage balance test from baseline: single leg stance from baseline - TELEHEALTH
Time frame: 12 weeks
How long a participant can stand on one foot to toe up to 60 seconds collected via telehealth
Change in 5 Times Sit to Stand Test from baseline
Time frame: 12 weeks
How long a participant can stand up and sit down from a standard chair with arms crossed across chest in seconds
Change in 5 Times Sit to Stand Test from baseline - TELEHEALTH
Time frame: 12 weeks
How long a participant can stand up and sit down from a standard chair with arms crossed across chest in seconds collected via telehealth
Change in Adapted Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Questionnaire from baseline
Time frame: 12 weeks
A patient-reported outcome measure that assesses perceived difficulty in completing physical tasks.
Change in Patient Health Questionnaire (PHQ-9) from baseline
Time frame: 12 weeks
A self-administered instrument for depression module, which scores each of the items as "0" (not at all) to "3" (nearly every day), with higher scores indicating worse depression
Change in Patient Health Questionnaire (PHQ-9) from baseline - TELEHEALTH
Time frame: 12 weeks
A self-administered instrument for depression module, which scores each of the items as "0" (not at all) to "3" (nearly every day), with higher scores indicating worse depression. Collected via telehealth
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline
Time frame: 12 weeks
A patient reported outcome measure containing 12 items that the participant rates his or her difficulties in maintaining personal care, occupational tasks and functioning in relation to family and society with a score range from 12 to 60, where higher scores indicate higher disability or loss of function.
Change in 12-item Self-Report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire from baseline - TELEHEALTH
Time frame: 12 weeks
A patient reported outcome measure containing 12 items that the participant rates his or her difficulties in maintaining personal care, occupational tasks and functioning in relation to family and society with a score range from 12 to 60, where higher scores indicate higher disability or loss of function. Collected via telehealth
Change in verbal fluency from baseline
Time frame: 12 weeks
A measure of cognition that involves asking the participant to name as many animals as they can in 60 seconds and then they are given a letter and asked to name all of the words that begin with that letter in 60 seconds. The more words the better the outcome.
Change in verbal fluency from baseline - TELEHEALTH
Time frame: 12 weeks
A measure of cognition that involves asking the participant to name as many animals as they can in 60 seconds and then they are given a letter and asked to name all of the words that begin with that letter in 60 seconds. The more words the better the outcome. Collected via telehealth.
Change in Digit Span test from baseline
Time frame: 12 weeks
A measure of cognition that involves asking the participant to recall a series of numbers. The more numbers recalled accurately the better the outcome.
Change in Digit Span test from baseline - TELEHEALTH
Time frame: 12 weeks
A measure of cognition that involves asking the participant to recall a series of numbers. The more numbers recalled accurately the better the outcome. Collected via telehealth
5 secondary outcomes
Change in Unified Huntington's Disease Rating Scale (UHDRS) Motor Scale from baseline
Time frame: 12 weeks
Change in Unified Huntington's Disease Rating Scale (UHDRS) Functional Assessment scale from baseline
Time frame: 12 weeks
Change in Unified Huntington's Disease Rating Scale (UHDRS) Independence scale from baseline
Time frame: 12 weeks
Change in Symbol Digit Modality Test (SDMT) from baseline
Time frame: 12 weeks
Change in the Stroop interference test from baseline
Time frame: 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2025.
Related trials for Huntington Disease
RecruitingPhase 2/3
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Huntington Disease
RecruitingPhase 3
Pridopidine Phase 3 Study in Huntington's Disease
Huntington Disease
Not yet recruiting
Creatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's Disease
Huntington Disease, Sarcopenia
Recruiting
Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study
Caregivers
RecruitingObservational study
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including, Sickle Cell Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Movement to Music in people with Huntington Disease, run by Ohio State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in 4 stage balance test from baseline: feet together from baseline (time frame: 12 weeks). The study lists 19 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.